Hemogenyx Pharmaceuticals Plc
Status: Publicly traded
Direct answer
Hemogenyx Pharmaceuticals Plc is publicly traded on LSE under the ticker HEMO.L.
Hemogenyx Pharmaceuticals Plc is a preclinical biotechnology company dedicated to the discovery, advancement, and commercialization of innovative therapies for various blood diseases. The firm's pipeline is heavily focused on creating novel solutions for the bone marrow and hematopoietic stem cell (BM/HSC) transplant sector. Key developments include a CDX bi-specific antibody, engineered to target challenging...
Can you invest in Hemogenyx Pharmaceuticals Plc?
Yes. Hemogenyx Pharmaceuticals Plc is publicly traded on LSE under the ticker HEMO.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Hemogenyx Pharmaceuticals Plc
Detailed equity research is provided by MarketSnap.